Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT02305381

Public ClinicalTrials.gov record NCT02305381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 23, 2026, 2:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide once weekly versus placebo as add-on to basal insulin alone or basal insulin in combination with metformin in subjects with type 2 diabetes.

Study identification

NCT ID
NCT02305381
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
397 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2014
Primary completion
Nov 20, 2015
Completion
Nov 20, 2015
Last update posted
Jun 10, 2019

2014 – 2015

United States locations

U.S. sites
72
U.S. states
27
U.S. cities
66
Facility City State ZIP Site status
Novo Nordisk Investigational Site Phoenix Arizona 85018
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Lomita California 90717
Novo Nordisk Investigational Site Los Angeles California 90057-3550
Novo Nordisk Investigational Site Northridge California 91325
Novo Nordisk Investigational Site Poway California 92064
Novo Nordisk Investigational Site Riverside California 92506
Novo Nordisk Investigational Site Roseville California 95661
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Van Nuys California 91405
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Waterbury Connecticut 06708
Novo Nordisk Investigational Site Bradenton Florida 34201
Novo Nordisk Investigational Site Fleming Island Florida 32003
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Port Charlotte Florida 33952
Novo Nordisk Investigational Site Spring Hill Florida 34609
Novo Nordisk Investigational Site Tampa Florida 33634
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Chicago Illinois 60611
Novo Nordisk Investigational Site Gillespie Illinois 62033
Novo Nordisk Investigational Site Skokie Illinois 60077
Novo Nordisk Investigational Site Avon Indiana 46123
Novo Nordisk Investigational Site Greenfield Indiana 46140
Novo Nordisk Investigational Site Indianapolis Indiana 46254
Novo Nordisk Investigational Site Muncie Indiana 47304
Novo Nordisk Investigational Site Council Bluffs Iowa 51501
Novo Nordisk Investigational Site Overland Park Kansas 66209
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Paducah Kentucky 42003
Novo Nordisk Investigational Site Metairie Louisiana 70002
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Waltham Massachusetts 02453
Novo Nordisk Investigational Site Ann Arbor Michigan 48106
Novo Nordisk Investigational Site Flint Michigan 48532
Novo Nordisk Investigational Site Kalamazoo Michigan 49009
Novo Nordisk Investigational Site Jackson Mississippi 39209
Novo Nordisk Investigational Site Las Vegas Nevada 89103
Novo Nordisk Investigational Site Las Vegas Nevada 89128
Novo Nordisk Investigational Site Teaneck New Jersey 07666
Novo Nordisk Investigational Site Albuquerque New Mexico 87102
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Cincinnati Ohio 45245
Novo Nordisk Investigational Site Cincinnati Ohio 45246
Novo Nordisk Investigational Site Cincinnati Ohio 45255
Novo Nordisk Investigational Site Dayton Ohio 45439
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73162-4704
Novo Nordisk Investigational Site Yukon Oklahoma 73099
Novo Nordisk Investigational Site Levittown Pennsylvania 19056-2404
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19114
Novo Nordisk Investigational Site Athens Tennessee 37303
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Amarillo Texas 79106
Novo Nordisk Investigational Site Dallas Texas 75251
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Fort Worth Texas 76132
Novo Nordisk Investigational Site Houston Texas 77008
Novo Nordisk Investigational Site Hurst Texas 76054
Novo Nordisk Investigational Site Katy Texas 77450
Novo Nordisk Investigational Site Mesquite Texas 75149
Novo Nordisk Investigational Site San Antonio Texas 78224
Novo Nordisk Investigational Site Sugar Land Texas 77478
Novo Nordisk Investigational Site Sugar Land Texas 77479
Novo Nordisk Investigational Site Bountiful Utah 84010
Novo Nordisk Investigational Site Richmond Virginia 23219
Novo Nordisk Investigational Site Kenosha Wisconsin 53144

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02305381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2019 · Synced Sep 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02305381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →